(4'-carbomethoxy-2'-nitrophenoxy)benzene | 73938-97-3

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: (4'-carbomethoxy-2'-nitrophenoxy)benzene
• 英文别名: methyl 3-nitro-4-phenoxybenzoate
• CAS: 73938-97-3
• 化学式: C₁₄H₁₁NO₅
• 分子量: 273.245
• InChiKey: XKANSZLJTSLUGZ-UHFFFAOYSA-N

物化性质

• 沸点：
  391.7±32.0 °C(Predicted)
• 密度：
  1.302±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.1
• 重原子数：
  20
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.07
• 拓扑面积：
  81.4
• 氢给体数：
  0
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  (4'-carbomethoxy-2'-nitrophenoxy)benzene 在 potassium phosphate 、 2-(二环己基膦)3,6-二甲氧基-2′,4′,6′-三异丙基-1,1′-联苯 、 palladium(II) acetylacetonate 作用下， 以 甲苯 为溶剂， 反应 24.0h， 以74%的产率得到methyl dibenzo[b,d]furan-2-carboxylate
  参考文献：
  名称：

  Pd催化反式分子内CH芳基化

  摘要：

  已经开发了钯催化的硝基芳烃的分子内C–H芳基化反应。硝基芳烃轴承拴系的芳基在邻位-位可以在从2-halonitroarenes一个步骤通过亲核芳族取代（S容易地制备Ñ AR）。在Pd / BrettPhos催化下，芳烃上C–NO 2键以及C–H键的活化产生了相应的联芳基键合，产率中等至极佳。

  DOI：

  10.1021/acs.orglett.9b01593
• 作为产物：
  描述：

  4-氟-3-硝基苯甲酸甲酯 、 苯酚 在 potassium carbonate 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 1.0h， 以88.3%的产率得到(4'-carbomethoxy-2'-nitrophenoxy)benzene
  参考文献：
  名称：

  Studies on selectin blocker. 9. SARs of non-sugar selectin blocker against E-, P-, L-selectin bindings

  摘要：

  As a part of study of selectin blockers, we have already reported that a non-sugar selectin antagonist (3) was successfully discovered using a computational screening (Hiramatsu, Y.; Tsukida, T.; Nakai, Y.; Inoue, Y.; Kondo, H. J. Med. Chem. 2000, 43 1476). To investigate the SARs of compound 3 against E-, P-, and L-selectins, we synthesized the derivatives of compound 3 and evaluated their inhibitory activities toward selectin bindings. The structural diversity of compound 3 contained the following. (1) a modification of the spacer unit (4-7), (2) a modification of the tail unit (8-11), (3) a modification of the head unit (12-18). As a result, it was found that a non-sugar based selectin blocker (3) could be a potential lead compound for E-, P-, and L-selectin blockers and some of the derivatives showed broad and/or selective inhibitory activities toward the E-, P-, and L-selectins. In addition, it was found that the experimental evidence well supported that the computational screening using 3D-pharmacophore model could be useful methodology to find out a new lead for the several type of selectin blockers, which included a broad and/or a selective inhibitor. (C) 2001 Published by Elsevier Science Ltd.

  DOI：

  10.1016/s0968-0896(01)00023-2

文献信息

• [EN] BENZAMIDE AND NICOTINAMIDE COMPOUNDS AND METHODS OF USING SAME<br/>[FR] BENZAMIDE ET COMPOSÉS DE NICOTINAMIDE ET LEURS PROCÉDÉS D'UTILISATION
  申请人：ONCOTARTIS INC

  公开号：WO2015100322A1

  公开（公告）日：2015-07-02

  The present disclosure provides benzamide and nicotinamide compounds and pharmaceutical uses of the compounds. The compounds can be used to treat, for example, cancers such hematopoietic cancers (e.g., leukemia). The preferred compounds of the invention contain a phenylethynyl moiety as well as an amine-based heterocyclyl or heteroaryl moiety attached to the benzamide or nicotinamide compound.

  本公开提供苯甲酰胺和烟酰胺化合物以及这些化合物的药用。这些化合物可用于治疗，例如，血液肿瘤等血液肿瘤（如白血病）。本发明的优选化合物包含苯乙炔基团以及连接到苯甲酰胺或烟酰胺化合物的胺基杂环基团或杂芳基团。
• Gopal, Ramanathan; Chandler, W. David; Robertson, Beverly E., Canadian Journal of Chemistry, 1980, vol. 58, # 7, p. 658 - 663
  作者：Gopal, Ramanathan、Chandler, W. David、Robertson, Beverly E.

  DOI：——

  日期：——